Compare Flux Power Holdings Inc (FLUX) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Flux Power Holdings Inc vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Flux Power Holdings Inc trades at $0.44 (market cap $10.60M), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 5486.8× Flux Power Holdings Inc's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.36% dividend while Flux Power Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Flux Power Holdings Inc for 20 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| FLUX | TAK | |
|---|---|---|
Market Cap | $10.60M | $58.16B |
Volume | 892,542 | 2,467,530 |
Sector | Industrials | Health |
52-Week High | $6.66 | $19.05 |
52-Week Low | $0.41 | $13.23 |
Typical Hold Time | 20 Days | 0 Days |
Enterprise Value | $18.80M | $86.04B |
Dividend Yield | — | 3.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLUX trades at $0.4902, down 0.55% on the day, amid a bearish technical signal with price near recent lows. The company reported a net loss of $6.67 million in 2025, with revenue declining to $42 million in 2026 and a negative net income margin of -17.68%. Recent news highlights a rejected unsolicited acquisition proposal from Solidion Technology, creating uncertainty.
Despite unanimous analyst buy ratings, fundamental challenges persist with negative profitability and cash flow concerns. The stock faces execution risks and competitive pressures, but potential acquisition interest could offer upside. Investors should weigh deteriorating financials against speculative M&A prospects.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Flux Power Holdings Inc
Flux Power designs and manufactures lithium-ion battery packs for industrial vehicles. Its sustainable energy solutions power material handling equipment like forklifts and airport ground support vehicles.
Read more on FLUX →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
